Bibliografisk note

Funding Information:
Research reported in this manuscript was primarily supported by Grant 1R01DK116790 to Tufts Medical Center from the National Institute of Diabetes and Digestive and Kidney Diseases . Support for studies included in analyses are listed in the supplementary material (Item S3). The CKiD Study is funded by the National Institute of Diabetes and Digestive and Kidney Diseases, with additional funding from the National Institute of Child Health and Human Development , and the National Heart, Lung, and Blood Institute (U01-DK-66143, U01-DK-66174, U24-DK-082194, U24-DK-66116). The funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

Funding Information:
Dr Inker report receiving grants to Tufts Medical Center from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Dr Levey reports being on the advisory board for AstraZeneca clinical trials for dapagliflozin and receiving NIH and NKF grants to his institution. Dr Yang reports grant U24-DK060990 from NIDDK and consulting fees as statistical editor for AJKD. Dr de Borst reports consulting fees and honoraria to institution from Astra Zeneca, Bayer, Pharmacosmos, and Sanofi Genzyme Amgen and Kyowa Kirin Pharma, and Vifor Pharma, respectively. Dr Maahs reports grants and contracts from NIH, Helmsley Charitable Trust, and NSF and consulting fees from Medtronic, Provention, Lifescan, and Eli Lilly. Dr Rossing reports receiving honoraria to his institution from Astra Zeneca, Bayer, Boehringer Ingelheim, Novo Nordisk, Gilead, Sanofi, Abbott, and Eli Lilly. Dr Schwartz reports grants and honoraria from NIDDK and Children’s Mercy Hospital. Dr Velez reports support from Dallas Nephrology Associates. Dr Klintmalam reports consulting fees from Immucor and honoraria from UCLA. Dr Kalil reports research grant from Eurofins. Dr Torres reports grants from Palladio Biosciences, Mironid, Blueprint Medicines, Tribune, Sanofi, Palladio, Reata, and Regulus and honoraria to institution from Otsuka Pharmaceuticals and Vertex Pharmaceuticals. Dr Seegmiller reports funding to institution from NIDDK. Dr Coresh reports grants from NKF and consulting fees from Healthy.io. Dr. Estrella reports NIDDK and NIA grant support, a research collaborative agreement with Bayer and consulting fees from Boehringer-Ingelheim, Inc. Dr. Warady reports receiving NIH funding as PI of the Chronic Kidney Disease in Children Study; consultancy fees from Amgen, GSK and Bayer and honoraria from UpToDate.